Cost Considerations Drive Lean Technology in Biomanufacturing

The approval of biosimilars for the US market has created a need for more efficient manufacturing processes.

Manufacturers are developing processes for cost efficiency and reliability using newer technology to compete with innovator products manufactured with legacy processes.

Innovations include more productive cell lines, single-use systems, and powerful analytical methods.

Download

.